• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃旁路手术后患者的餐后低血糖是由葡萄糖诱导的白细胞介素-1β介导的。

Postprandial Hypoglycemia in Patients after Gastric Bypass Surgery Is Mediated by Glucose-Induced IL-1β.

机构信息

Clinic of Endocrinology, Diabetes and Metabolism University Hospital Basel, and Department of Biomedicine, University of Basel, Basel, Switzerland; Endocrinology and Metabolic Diseases, Cantonal Hospital Olten, Olten, Switzerland.

Clinic of Endocrinology, Diabetes and Metabolism University Hospital Basel, and Department of Biomedicine, University of Basel, Basel, Switzerland.

出版信息

Cell Metab. 2020 Apr 7;31(4):699-709.e5. doi: 10.1016/j.cmet.2020.02.013. Epub 2020 Mar 19.

DOI:10.1016/j.cmet.2020.02.013
PMID:32197070
Abstract

Postprandial hypoglycemia is a disabling complication of the treatment of obesity by gastric bypass surgery. So far, no therapy exists, and the underlying mechanisms remain unclear. Here, we hypothesized that glucose-induced IL-1β leads to an exaggerated insulin response in this condition. Therefore, we conducted a placebo-controlled, randomized, double-blind, crossover study with the SGLT2-inhibitor empagliflozin and the IL-1 receptor antagonist anakinra (clinicaltrials.govNCT03200782; n = 12). Both drugs reduced postprandial insulin release and prevented hypoglycemia (symptomatic events requiring rescue glucose: placebo = 7/12, empagliflozin = 2/12, and anakinra = 2/12, pval = 0.013; nadir blood glucose for placebo = 2.4 mmol/L, 95% CI 2.18-2.62, empagliflozin = 2.69 mmol/L, 95% CI 2.31-3.08, and anakinra = 2.99 mmol/L, 95% CI 2.43-3.55, pval = 0.048). Moreover, analysis of monocytes ex vivo revealed a hyper-reactive inflammatory state that has features of an exaggerated response to a meal. Our study proposes a role for glucose-induced IL-1β in postprandial hypoglycemia after gastric bypass surgery and suggests that SGLT2-inhibitors and IL-1 antagonism may improve this condition.

摘要

胃旁路手术后发生的餐后低血糖是肥胖治疗的一种致残性并发症。目前尚无治疗方法,其潜在机制仍不清楚。在这里,我们假设葡萄糖诱导的 IL-1β 导致这种情况下胰岛素反应过度。因此,我们进行了一项安慰剂对照、随机、双盲、交叉研究,使用 SGLT2 抑制剂恩格列净和 IL-1 受体拮抗剂阿那白滞素(clinicaltrials.govNCT03200782;n=12)。两种药物均降低了餐后胰岛素释放并预防了低血糖(需要抢救葡萄糖的症状性事件:安慰剂=7/12,恩格列净=2/12,阿那白滞素=2/12,pval=0.013;安慰剂的血糖最低点为 2.4mmol/L,95%CI 2.18-2.62,恩格列净=2.69mmol/L,95%CI 2.31-3.08,阿那白滞素=2.99mmol/L,95%CI 2.43-3.55,pval=0.048)。此外,对体外单核细胞的分析显示出一种过度活跃的炎症状态,具有对餐食反应过度的特征。我们的研究提出了胃旁路手术后餐后低血糖与葡萄糖诱导的 IL-1β 之间的关系,并表明 SGLT2 抑制剂和 IL-1 拮抗作用可能改善这种情况。

相似文献

1
Postprandial Hypoglycemia in Patients after Gastric Bypass Surgery Is Mediated by Glucose-Induced IL-1β.胃旁路手术后患者的餐后低血糖是由葡萄糖诱导的白细胞介素-1β介导的。
Cell Metab. 2020 Apr 7;31(4):699-709.e5. doi: 10.1016/j.cmet.2020.02.013. Epub 2020 Mar 19.
2
Study protocol for a randomised, double-blind, placebo-controlled crossover trial assessing the impact of the SGLT2 inhibitor empagliflozin on postprandial hypoglycaemia after gastric bypass.胃旁路术后 SGLT2 抑制剂恩格列净对餐后低血糖影响的随机、双盲、安慰剂对照交叉试验研究方案。
BMJ Open. 2022 Sep 19;12(9):e060668. doi: 10.1136/bmjopen-2021-060668.
3
Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass.一项每日一次恩格列净 25mg 治疗 Roux-en-Y 胃旁路术后餐后低血糖的随机、双盲、安慰剂对照交叉试验。
Diabetes Technol Ther. 2023 Jul;25(7):467-475. doi: 10.1089/dia.2023.0036. Epub 2023 Jun 5.
4
Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes.在肥胖且血糖控制不佳的 2 型糖尿病患者中,加用恩格列净可改善血糖控制,减少胰岛素用量,且不增加低血糖风险。
Diabetes Care. 2014 Jul;37(7):1815-23. doi: 10.2337/dc13-3055. Epub 2014 Jun 14.
5
Dasiglucagon Effectively Mitigates Postbariatric Postprandial Hypoglycemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.Dasiglucagon 有效缓解减重术后餐后低血糖:一项随机、双盲、安慰剂对照、交叉试验。
Diabetes Care. 2022 Jun 2;45(6):1476-1481. doi: 10.2337/dc21-2252.
6
The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion.钠-葡萄糖协同转运蛋白 2 抑制剂恩格列净通过靶向 TRAF3IP2/ROS/NLRP3/Caspase-1 依赖性白细胞介素-1β和白细胞介素-18 的分泌来抑制白细胞介素-17A 诱导的人主动脉平滑肌细胞增殖和迁移。
Cell Signal. 2021 Jan;77:109825. doi: 10.1016/j.cellsig.2020.109825. Epub 2020 Nov 4.
7
Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.胃旁路术后胰高血糖素样肽 1 受体阻断纠正餐后低血糖。
Gastroenterology. 2014 Mar;146(3):669-680.e2. doi: 10.1053/j.gastro.2013.11.044. Epub 2013 Dec 4.
8
Predictors of Postprandial Hypoglycemia After Gastric Bypass Surgery: a Retrospective Case-Control Study.胃旁路手术后餐后低血糖的预测因素:一项回顾性病例对照研究。
Obes Surg. 2021 Jun;31(6):2497-2502. doi: 10.1007/s11695-021-05277-1. Epub 2021 Feb 23.
9
Roux en Y gastric bypass hypoglycemia resolves with gastric feeding or reversal: Confirming a non-pancreatic etiology.Roux-en-Y 胃旁路术后低血糖通过胃饲或逆转解决:证实为非胰腺病因。
Mol Metab. 2018 Mar;9:15-27. doi: 10.1016/j.molmet.2017.12.011. Epub 2018 Jan 31.
10
Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass: A Randomized, Double-Blind, Placebo-Controlled Trial.胃旁路术后餐后低血糖的 dasiglucagon 治疗:一项随机、双盲、安慰剂对照试验。
Diabetes Care. 2023 Dec 1;46(12):2208-2217. doi: 10.2337/dc23-1193.

引用本文的文献

1
Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial-the CanpHy study.卡那单抗治疗餐后低血糖:一项随机、安慰剂对照、平行组、双盲、多中心、优效性试验的研究方案——卡那单抗治疗餐后低血糖(CanpHy)研究
BMJ Open. 2025 May 26;15(5):e097981. doi: 10.1136/bmjopen-2024-097981.
2
Postprandial hypoglycemia as a complication of bariatric and metabolic surgery: a comprehensive review of literature.餐后低血糖作为减重及代谢手术的并发症:文献综述
Front Surg. 2024 Nov 1;11:1449012. doi: 10.3389/fsurg.2024.1449012. eCollection 2024.
3
Targeting the NLRP3 inflammasome-IL-1β pathway in type 2 diabetes and obesity.
靶向2型糖尿病和肥胖中的NLRP3炎性小体-白细胞介素-1β途径。
Diabetologia. 2025 Jan;68(1):3-16. doi: 10.1007/s00125-024-06306-1. Epub 2024 Nov 4.
4
Remission of type 2 diabetes: position statement of the Italian society of diabetes (SID).2 型糖尿病缓解:意大利糖尿病学会(SID)立场声明。
Acta Diabetol. 2024 Oct;61(10):1309-1326. doi: 10.1007/s00592-024-02317-x. Epub 2024 Jun 28.
5
Adiposity, immunity, and inflammation: interrelationships in health and disease: a report from 24th Annual Harvard Nutrition Obesity Symposium, June 2023.肥胖、免疫与炎症:健康与疾病中的相互关系:第 24 届哈佛营养肥胖研讨会报告,2023 年 6 月。
Am J Clin Nutr. 2024 Jul;120(1):257-268. doi: 10.1016/j.ajcnut.2024.04.029. Epub 2024 May 3.
6
Society for Endocrinology guidelines for the diagnosis and management of post-bariatric hypoglycaemia.内分泌学会关于减肥后低血糖症诊断和管理的指南。
Endocr Connect. 2024 May 1;13(5). doi: 10.1530/EC-23-0285. Epub 2024 Apr 1.
7
Arachidonic acid inhibition of the NLRP3 inflammasome is a mechanism to explain the anti-inflammatory effects of fasting.花生四烯酸抑制 NLRP3 炎性小体是禁食抗炎作用的机制。
Cell Rep. 2024 Feb 27;43(2):113700. doi: 10.1016/j.celrep.2024.113700. Epub 2024 Jan 23.
8
[Postoperative management].[术后管理]
Wien Klin Wochenschr. 2023 Nov;135(Suppl 6):729-742. doi: 10.1007/s00508-023-02272-7. Epub 2023 Oct 11.
9
Effects of Roux-en-Y gastric bypass on the metabolic profile and systemic inflammatory status of women with metabolic syndrome: randomized controlled clinical trial.Roux-en-Y胃旁路术对代谢综合征女性代谢谱和全身炎症状态的影响:随机对照临床试验
Diabetol Metab Syndr. 2023 Feb 14;15(1):19. doi: 10.1186/s13098-023-00986-2.
10
Effect of Dietary Pomelo Peel Powder on Growth Performance, Diarrhea, Immune Function, Antioxidant Function, Ileum Morphology, and Colonic Microflora of Weaned Piglets.日粮添加柚子皮粉对断奶仔猪生长性能、腹泻、免疫功能、抗氧化功能、回肠形态及结肠微生物区系的影响
Animals (Basel). 2022 Nov 20;12(22):3216. doi: 10.3390/ani12223216.